A detailed history of Parsec Financial Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Parsec Financial Management, Inc. holds 114,024 shares of ABT stock, worth $13.1 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
114,024
Previous 84,385 35.12%
Holding current value
$13.1 Million
Previous $9.27 Million 24.61%
% of portfolio
0.49%
Previous 0.41%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 06, 2023

BUY
$96.86 - $114.01 $2.87 Million - $3.38 Million
29,639 Added 35.12%
114,024 $11.5 Million
Q4 2022

Feb 06, 2023

BUY
$95.06 - $111.52 $284,134 - $333,333
2,989 Added 3.67%
84,385 $9.27 Million
Q3 2022

Nov 07, 2022

SELL
$96.76 - $112.03 $74,892 - $86,711
-774 Reduced 0.94%
81,396 $7.88 Million
Q2 2022

Jul 06, 2022

BUY
$102.07 - $123.37 $65,528 - $79,203
642 Added 0.79%
82,170 $8.93 Million
Q1 2022

May 09, 2022

BUY
$114.02 - $139.04 $11,173 - $13,625
98 Added 0.12%
81,528 $9.65 Million
Q4 2021

Feb 08, 2022

BUY
$115.53 - $141.46 $39,164 - $47,954
339 Added 0.42%
81,430 $11.5 Million
Q3 2021

Nov 10, 2021

BUY
$116.66 - $129.06 $31,148 - $34,459
267 Added 0.33%
81,091 $10.3 Million
Q2 2021

Jul 26, 2021

SELL
$105.79 - $124.53 $11,213 - $13,200
-106 Reduced 0.13%
80,824 $9.37 Million
Q1 2021

Apr 23, 2021

SELL
$108.84 - $128.23 $4,135 - $4,872
-38 Reduced 0.05%
80,930 $9.7 Million
Q4 2020

Feb 03, 2021

SELL
$105.0 - $114.42 $187,950 - $204,811
-1,790 Reduced 2.16%
80,968 $8.87 Million
Q3 2020

Nov 06, 2020

SELL
$91.64 - $111.29 $196,751 - $238,939
-2,147 Reduced 2.53%
82,758 $9.01 Million
Q2 2020

Aug 04, 2020

BUY
$76.57 - $98.0 $17,228 - $22,050
225 Added 0.27%
84,905 $7.76 Million
Q1 2020

May 08, 2020

SELL
$62.82 - $91.86 $610,484 - $892,695
-9,718 Reduced 10.29%
84,680 $6.68 Million
Q4 2019

Jan 29, 2020

SELL
$78.51 - $87.4 $68,460 - $76,212
-872 Reduced 0.92%
94,398 $8.2 Million
Q3 2019

Oct 23, 2019

SELL
$81.84 - $88.74 $179,802 - $194,961
-2,197 Reduced 2.25%
95,270 $7.97 Million
Q2 2019

Jul 23, 2019

SELL
$72.88 - $85.0 $9.93 Million - $11.6 Million
-136,319 Reduced 58.31%
97,467 $0
Q1 2019

Apr 25, 2019

SELL
$66.22 - $80.06 $892,049 - $1.08 Million
-13,471 Reduced 5.45%
233,786 $18.7 Million
Q4 2018

Jan 29, 2019

SELL
$65.56 - $74.27 $461,017 - $522,266
-7,032 Reduced 2.77%
247,257 $17.9 Million
Q3 2018

Oct 30, 2018

SELL
$60.81 - $73.36 $583,107 - $703,449
-9,589 Reduced 3.63%
254,289 $18.7 Million
Q2 2018

Jul 26, 2018

BUY
$57.57 - $63.54 $141,391 - $156,054
2,456 Added 0.94%
263,878 $16.1 Million
Q1 2018

Apr 25, 2018

BUY
$56.27 - $63.62 $266,044 - $300,795
4,728 Added 1.84%
261,422 $15.7 Million
Q4 2017

Jan 26, 2018

BUY
$53.68 - $57.47 $206,560 - $221,144
3,848 Added 1.52%
256,694 $14.7 Million
Q3 2017

Oct 25, 2017

BUY
$48.06 - $53.64 $12.2 Million - $13.6 Million
252,846
252,846 $13.5 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Parsec Financial Management, Inc. Portfolio

Follow Parsec Financial Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parsec Financial Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Parsec Financial Management, Inc. with notifications on news.